Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

NorwayBack to Norway

Clinical trials in Bodo – page 2

36 clinical trials in Bodo, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Bodo at a glance
36
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

36 trials in Bodo

Open in trial search

Osteoarthritis

Recruiting

Study on Painful Thumb Osteoarthritis: Comparing Triamcinolone Acetonide, Sodium Chloride, and Occupational Therapy for Patients with Inflammatory Thumb Joint Pain

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Diakonhjemmet Sykehus AS

Obesity

Recruiting

Study on Semaglutide and Low Energy Diet for Obesity in Adolescents Aged 12-17

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Semaglutide
  • Sponsor:Vestfold Hospital Trust

Metastatic malignant melanoma

Recruiting

Study Comparing Subcutaneous and Intravenous Nivolumab and Relatlimab for Patients with Untreated Metastatic or Unresectable Melanoma

InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

HER2 positive breast cancer

Recruiting

Study Comparing Trastuzumab Deruxtecan with Standard Treatment for Patients with HER2-positive Breast Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Aprepitant
  • Sponsor:Karolinska University Hospital

Cerebrovascular accident

Recruiting

Study on Tranexamic Acid and Sodium Chloride for Patients with Stroke-Related Brain Bleeding

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:University Of Nottingham

Multiple sclerosis

Recruiting

Comparison of ocrelizumab and rituximab treatment in adults with active relapsing-remitting multiple sclerosis

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:Helse Bergen HF

Small cell lung cancer limited stage

Not yet recruiting

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology

Cluster headache

Not yet recruiting

A Study of Candesartan to Prevent Chronic Cluster Headache Attacks in Adults with Chronic Cluster Headache

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Candesartan
  • Sponsor:Helse Bergen HF

Cluster headache

Not yet recruiting

A Study of Candesartan Compared to Placebo in Adults with Episodic Cluster Headache to Prevent Severe Headache Attacks

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Candesartan
  • Sponsor:Helse Bergen HF

Chronic kidney disease

Not recruiting

Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:AstraZeneca AB

Chronic obstructive pulmonary disease

Not recruiting

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB

Chronic obstructive pulmonary disease

Not recruiting

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:AstraZeneca AB

Other cities in Norway

The busiest research cities in the country

All 54 cities in Norway

Clinical research in Bodo

What the registry says about research in the country

01 Respiratory Medicine

Research focusing on pulmonary diseases and respiratory conditions, including studies on treatment approaches for idiopathic pulmonary fibrosis and advanced lung cancer therapies.

  • Pulmonary Fibrosis Treatment Studies
  • Small-Cell Lung Cancer Therapy
  • Pediatric Respiratory Infections

Clinical trials evaluating innovative treatments combining immunotherapy with conventional approaches.

02 Cardiovascular Research

Comprehensive studies addressing cardiovascular disorders, from stroke prevention to cholesterol management and acute cardiac conditions.

  • Stroke Prevention in Atrial Fibrillation
  • Acute Myocardial Infarction Management
  • Cholesterol Control Therapies

Innovative approaches in preventive cardiology and acute cardiac care interventions.

03 Oncology Studies

Advanced cancer research including precision medicine trials for various cancer types, with particular focus on melanoma and breast cancer treatments.

  • Pancreatic Cancer Therapies
  • Advanced Melanoma Treatment
  • HER2-Positive Breast Cancer

Pioneering targeted therapies and immunotherapy approaches for cancer treatment.

04 Chronic Conditions

Research addressing long-term health conditions including rheumatoid arthritis, chronic kidney disease, and obesity management.

  • Adolescent Obesity Treatment
  • Chronic Kidney Disease
  • Arthritis Management

Focus on developing effective long-term treatment strategies for chronic conditions.

Back to NorwayAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.